Literature DB >> 15868364

[Facioscapulohumeral muscle dystrophy and heart disease].

P Emmrich1, V Ogunlade, T Gradistanac, S Daneschnejad, M C Koch, R Schober.   

Abstract

Cardiac involvement is well known in a number of skeletomuscular diseases but not in facio-scapulohumeral muscular dystrophy (FSHD). We report on a 71 year old woman with progressive cardiac insufficiency in FSHD, which was also confirmed by molecular analysis in one of the two daughters affected by the disease. Autopsy of the deceased patient showed the typical changes in skeletal muscles including focal inflammatory infiltrates in the diaphragm and, in addition, cardiac muscular involvement. The histological changes resembled those seen in primary cardiomyopathy despite the normal muscle mass volume. Both clinically and morphologically, the cardiac disease was the cause of death in this patient with FSHD.

Entities:  

Mesh:

Year:  2005        PMID: 15868364     DOI: 10.1007/s00392-005-0223-4

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  21 in total

Review 1.  Molecular diagnosis of facioscapulohumeral muscular dystrophy.

Authors:  Meena Upadhyaya; David N Cooper
Journal:  Expert Rev Mol Diagn       Date:  2002-03       Impact factor: 5.225

2.  Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy.

Authors:  C Wijmenga; J E Hewitt; L A Sandkuijl; L N Clark; T J Wright; H G Dauwerse; A M Gruter; M H Hofker; P Moerer; R Williamson
Journal:  Nat Genet       Date:  1992-09       Impact factor: 38.330

3.  Facioscapulohumeral muscular dystrophy gene in Dutch families is not linked to markers for familial adenomatous polyposis on the long arm of chromosome 5.

Authors:  C Wijmenga; R R Frants; O F Brouwer; H M van der Klift; P Meera Khan; G W Padberg
Journal:  J Neurol Sci       Date:  1990-02       Impact factor: 3.181

4.  The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis.

Authors:  K A Frankel; R J Rosser
Journal:  Hum Pathol       Date:  1976-07       Impact factor: 3.466

5.  Inflammatory response in facioscapulohumeral muscular dystrophy (FSHD): immunocytochemical and genetic analyses.

Authors:  K Arahata; T Ishihara; H Fukunaga; S Orimo; J H Lee; K Goto; I Nonaka
Journal:  Muscle Nerve Suppl       Date:  1995

6.  Autopsy analyses of the muscular dystrophies.

Authors:  T Moriuchi; N Kagawa; M Mukoyama; K Hizawa
Journal:  Tokushima J Exp Med       Date:  1993-06

7.  [A patient with dermatomyositis and systemic sclerosis with preferential facioscapulohumeral muscle involvement and fatal cardiomyopathy].

Authors:  Y Oya; J Toyama; M Ogawa; I Nonaka; M Kawai
Journal:  Rinsho Shinkeigaku       Date:  2001-06

8.  Facioscapulohumeral muscular dystrophy: evidence for selective, genetic electrophysiologic cardiac involvement.

Authors:  W G Stevenson; J K Perloff; J N Weiss; T L Anderson
Journal:  J Am Coll Cardiol       Date:  1990-02       Impact factor: 24.094

9.  Atypical phenotypes in patients with facioscapulohumeral muscular dystrophy 4q35 deletion.

Authors:  Michael Krasnianski; Katharina Eger; Stephan Neudecker; Sibylle Jakubiczka; Stephan Zierz
Journal:  Arch Neurol       Date:  2003-10

10.  Location of facioscapulohumeral muscular dystrophy gene on chromosome 4.

Authors:  C Wijmenga; R R Frants; O F Brouwer; P Moerer; J L Weber; G W Padberg
Journal:  Lancet       Date:  1990-09-15       Impact factor: 79.321

View more
  4 in total

1.  Facioscapulohumeral Muscular Dystrophy: More Complex than it Appears.

Authors:  G Ricci; M Zatz; R Tupler
Journal:  Curr Mol Med       Date:  2014       Impact factor: 2.222

Review 2.  Management of cardiac involvement in muscular dystrophies: paediatric versus adult forms.

Authors:  Alberto Palladino; Paola D'Ambrosio; Andrea Antonio Papa; Roberta Petillo; Chiara Orsini; Marianna Scutifero; Gerardo Nigro; Luisa Politano
Journal:  Acta Myol       Date:  2016-12

3.  Subclinical myocardial injury in patients with Facioscapulohumeral muscular dystrophy 1 and preserved ejection fraction - assessment by cardiovascular magnetic resonance.

Authors:  Edyta Blaszczyk; Ulrike Grieben; Florian von Knobelsdorff-Brenkenhoff; Peter Kellman; Luisa Schmacht; Stephanie Funk; Simone Spuler; Jeanette Schulz-Menger
Journal:  J Cardiovasc Magn Reson       Date:  2019-04-29       Impact factor: 5.364

4.  Baroreflex sensitivity in facioscapulohumeral muscular dystrophy.

Authors:  Miguel Anselmo; Shandon Coffman; Mia Larson; Kathryn Vera; Emma Lee; Mary McConville; Michael Kyba; Manda L Keller-Ross
Journal:  Physiol Rep       Date:  2022-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.